• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Bobby Buka MD Dermatology and Brooklyn Dermatology Merge to Form Enhanced Practice, The Dermatology Specialists

Share:

May 20, 2019

Today, Bobby Buka MD Dermatology, a leading dermatology practice in New York City, and Brooklyn Dermatology, a Brooklyn-based dermatology group, announced they are merging to form The Dermatology Specialists. The joined practice will offer the same premier dermatological care both practices are known for, now across ten locations in Manhattan, Queens and Brooklyn. Dr. Bobby Buka will become the Chief Executive Officer and Dr. Sourab Choudhury will serve as the joint practice’s Chief Medical Officer.

“Our goal is to continue to deliver the highest quality of patient care to local communities around New York City,” says Dr. Bobby Buka. “As a result of the merger, our patients will have access to a larger network of trusted dermatologists. We’re excited to further strengthen our offering to patients and fulfill the needs of this diverse city.”

The practice offers extensive medical dermatological services, including acne, rosacea and eczema, and cosmetic services like BOTOX Cosmetic, lasers and volume-restoring fillers. The practice stands at the forefront of dermatological advancements, operating its own research facilities and processing labs with resident pathologists that offer patients quicker, more accurate results.

Drs. Buka and Choudhury represent a small group of doctors in NYC who have completed fellowships in pediatric dermatology, making The Dermatology Specialists one of the largest practices in NYC to offer the specialization.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“TDS is high-caliber and high-touch,” said Dr. Sourab Choudhury. “We have gentle hands and gentle hearts for patients of all ages and needs.”

Both Drs. Buka and Choudhury have built powerful reputations as dermatologists. Dr. Buka was awarded “New York City’s Most Sought-After Dermatologist” by NBC NonStop. His expertise has been featured in dermatology textbooks and medical journals alongside major media outlets like Good Morning America, The Today Show, and Inside Edition. Dr. Buka is also a contributing founder and Chief Science Officer of skincare line First Aid Beauty. Dr. Choudhury was appointed Chief of Pediatric Dermatology of the Long Island College Hospital in 2003. He is affiliated with both LICH and St John’s, and has taught residents there for more than a decade. He has built a name as a leader in world-class dermatology, specializing in pediatric skincare and known for his compassionate care and knowledgeable team.

The Dermatology Specialists opens its tenth office on June 10th in Brooklyn’s Bushwick neighborhood, its eleventh in Greenpoint in August, and has plans for further expansions over the next few years.

Date: May 20, 2019

Source: Markets Insider

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Healthcare: AI That Saves LivesHealthcare: AI That Saves Lives
  • Will Value-Based Care Finally Fix EHRs Too?Will Value-Based Care Finally Fix EHRs Too?
  • Medtronic Awarded Emergency Authorization for Compact Ventilator to Support COVID-19 PatientsMedtronic Awarded Emergency Authorization for Compact Ventilator to Support COVID-19 Patients
  • Community Engagement Is Key To Clinical Trial Recruitment And DiversityCommunity Engagement Is Key To Clinical Trial Recruitment And Diversity
  • Australis Enters Letter of Intent to Acquire Rthm Technologies Inc.Australis Enters Letter of Intent to Acquire Rthm Technologies Inc.
  • Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead AssetVarian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
  • Google Rolls Out Mobile App Version of Care StudioGoogle Rolls Out Mobile App Version of Care Studio
  • Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications